AJO LP’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

AJO LP’s Portfolio SCMP Stock Details SCMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-32,698	Closed	-$443K	–	599
2016 Q4	$443K	Sell	32,698 -28,269	-46%	-$394K	﹤0.01%	471
2016 Q3	$751K	Buy	+60,967	New	+$718K	﹤0.01%	429

Other funds holding SCMP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Redwood Investments Boston, Massachusetts $267M AUM 11.99% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AJO LP's SCMP Position: Q1 2017 in Review

AJO LP sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2017, closing a stake of 32,698 shares — an estimated $443K sold.

AJO LP first reported a position in SCMP in Q3 2016 and held it in 2 quarters. The position peaked at $751K in Q3 2016. 167 funds tracked by Wall St. Rank hold SCMP as of Q1 2017.

AJO LP reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2017 after selling out during the quarter.
AJO LP sold 32,698 Sucampo Pharmaceuticals, Inc. shares in Q1 2017, an estimated $443K.
AJO LP first reported a position in Sucampo Pharmaceuticals, Inc. in Q3 2016 and held it in 2 quarters.
AJO LP's Sucampo Pharmaceuticals, Inc. position peaked at $751K in Q3 2016.
167 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2017.

Based on AJO LP's 13F filing for Q1 2017, filed 15 May 2017.